ArticleMolecular therapy. Oncology2025
Nanobody-based canine PD-L1-targeting immune checkpoint inhibitors for cancer therapy in dogs.
Morgane Di Palma Subran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it